Percutaneous endoscopic gastrostomy site metastases in head and neck cancer: use of FDG PET-CT
In Diagnostic Interventional Radiology
Contributor(s): Deshpande M | Pathak S | Arora A | Singh N | Shah S | Sharma AR | Rangarajan V | nilpurandare@gmail.com | Purandare NC.
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
Tata Memorial Hospital | Available | AR8604 |
PURPOSE: To retrospectively evaluate the utility of positron emission tomography-computed tomography (PETCT) in the diagnosis of percutaneous endoscopic gastroscopy (PEG) site metastases in head and neck cancer. MATERIALS AND METHODS: From the database of 250 patients of head and neck cancer who were referred for PET-CT over 2 years (from January 2005 to January 2007), 6 patients who had PEG tube placement were considered for the study. Imaging was performed on a GE Discovery ST PET-CT system after intravenous injection of 370 MBq (10 mCi) of < sup > 18 < /sup > F-fluorodeoxyglucose (FDG). RESULTS: Intense FDG uptake with an associated soft tissue mass was seen at the PEG site in 3 patients and mild uptake was seen in 2 patients. Biopsy revealed PEG site metastases in 2 patients, abscess in 1 patient, and granulation tissue in 1 patient. Intense uptake with an associated soft tissue mass suggested the diagnosis of metastasis. Stranding of the peristomal fat seen on the CT component of the PET-CT indicated a
There are no comments for this item.